ArticleCancer biology & therapy2016

The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines.

Maria Cosenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.